Get started
$NRX.V Outpaces Biotech Peers Following TSX.V Listing The biotech sector is presenting exciting opportunities for investors despite the broader downturn in global equity markets. Many of the best biotech companies and ETFs have both strong drug candidate pipelines in the works as well as winning drugs and therapeutic products already on the market. The COVID-19 pandemic has proven and created massive opportunities for the biotechnology sector as a whole, particularly so around innovative players that are developing therapeutic solutions with disruptive potential. One new player to the field is Nurexone Biologic (NRX.V), a new listee on the TSXV exchange that is redefining exosome therapeutics for application to traumatic brain and spinal cord injuries. It is creating a platform for biologically-guided ExoTherapy that will be administered minimally invasively to patients who have had catastrophic spinal cord injuries. Since July 15th, NRX +26% as it attracts new investors and institutional players begin to trade the equity. In comparison, the TSX/SPX composite index charted 6% gains, indicating that NRX far outperformed the market baseline over the course of the summer rally. Relative to sectoral ETFs, Nurexone is also trading strong. IBBQ is +6.9% and XBI +6% over the same timeframe NRX is +26%; it is important to note that over this period, the company did not release any price sensitive announcements that would otherwise account for its significant bullish price movement. Further, exosome-based equities are one area of the wider biotech industry that has continuously traded robustly despite subpar performance for equity markets this year. Sectoral competitors are mixed bag, with KMPH +4.8% while APTO is down 4.4%. Kodiak Biosciences (KOD) jumped 20%, though it still lags behind NRX's 26% increase. This indicates that as exosome therapeutic developers struggle to maintain forward momentum amidst the backdrop of a challenging macroeconomic landscape, NRX is outperforming both sectoral ETFs and direct competitors. Though its a newby to capital markets, so far Nurexone is standing out as the bullish outlier with LT potential.
TSXV:NRX
by BiotechBrandon
CRAFTPORT CANADASun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
CSE:CFT
by Sunstorminvest
SILVER PREDATOR CANADA Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
TSXV:SPD
by Sunstorminvest
THYMBAL RESOURCES CANADASun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
T
by Sunstorminvest
Telus no follow thruTelus just released their earnings today and they were just as good as estimated but never the less the stock had no reaction and is now selling off. The chart looks real ugly if you look at the Monthly and Quarterly window we have managed no follow thru after the big move down to start the year, the bulls are running out of time to step in and take this higher. My target is $27.59 for the quarterly and monthly low once we break past that I think we take out last years low of $24.93 I am looking at september 16th expiry monthly calls strike at either 29/28 or 27
TSX:TShort
by AthenaCapital
5
Breakthrough Discovery: AccuTOX Effectively Kills Cancer Cells by @newsfile on 2 Aug 2022, 03:15 Breakthrough Discovery: AccuTOX(TM) Effectively Kills Cancer Cells by Directly Eliciting DNA Damage Vancouver, British Columbia--(Newsfile Corp. - August 2, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the discovery of a novel DNA damaging function triggered by one of its lead compounds AccuTOXTM, which effectively elicits cell death in cancer cells. Cancer can be generally described as a state of uncontrolled cell proliferation. This is mainly due to losses in the ability of a given cell to activate its own cell death via a specific set of proteins known to sense unusual activities. Although it is difficult to reactivate these specific pathways to elicit cancer cell death, AccuTOXTM can address this. Defence previously reported (see press release of June 22, 2021) the discovery of an AccumTM variant, AccuTOXTM, capable of controlling cancer growth when injected directly in tumors. The use of AccuTOXTM in combination with multiple immune-checkpoints results in a survival rate between 60% and 100%, based on the pre-clinical tumor models studies in mice. The mode of action of AccuTOXTM approached is a non-biased transcriptomic application and revealed that the compound impairs several crucial pathways including DNA replication, cell division, nuclear integrity, and multiple modifications affecting DNA activity. The accumulation of exhaustive cell repair mechanisms triggered by AccuTOXTM combined to the build-up of misfolded proteins and generation of free radicals induce irreversible DNA damages leading to a general collapse in several cellular pathways resulting in effective cancer cell death. "Defence's breakthrough discovery with its AccuTOXTM formulation as a novel potent small molecule capable of killing cancer cells is a significant advancement and development for oncology cancer treatment applications with AccumTM. Discovering that AccuTOXTM can behave as a chemotherapeutic agent targeting the DNA of cancer cells and an immune-checkpoint inhibitor booster is a new discovery that is highly valuable to Defence's pipeline and future potential developments. The AccuTOXTM presents a novel discovery as a platform for targeting multiple cancers. This novel discovery creates significant values and applications to our Antibody Drug Conjugate ("ADC") pipeline. Results are convincing that AccuTOXTM is the perfect potent small molecule to use in the development of our own ADC," says Mr. Plouffe, the CEO of Defence Therapeutics. Defence is currently conducting GLP studies on AccuTOXTM prior to initiate a Phase I trial in North America.
CSE:DTCLong
by agstockpicks
Tourmaline Oil - Beauty to Beast and Beast to BeautyTourmaline's pullback from it's $80 all time high and its bounce off the previous all time high is simply not deep enough, as evidenced by today's stop run over the June monthly close, which also produced one of those very credible "head and shoulders" patterns, on the back of the maniacs in the Natural Gas market running a monster short squeeze that ruined a lot of Q2s for "hedge funds." WTI and NatGas are going to dump. Stocks are going to dump. It's not going to be a very pleasant period of time. But, natural gas and oil are something that the ruling regime cannot do without, because transportation and electricity rely entire upon them. Oil is going to set a new all time high, and so is natural gas. They will do it at the same time, as the middle class is already experiencing maximum pain. This will give the central banks the handle they need to increasingly tighten, in addition to giving the Marxist-Leninist globalists a pretext to install social credit digital identification for the sake of fuel rationing. Don't believe? Google Sri Lanka fuel rationing QR code & Ireland oil shortage war game. Anyway, for Tourmaline, this Alberta gem is apt to give you a fine buying opportunity as commodities dump and the stock market crashes under $55 and $50. The target is simply $100+. With stops below the July 2021 highs of $35, you get an RR of 4. Oil and natural gas, when they bounce, should be painfully brutal to bears. The situation should go parabolic, but it won't go all that high, and it won't go for all that long. Think about what gold did when it set a new all time high, but faster, and for less time. After the Party is over, the lights turn on and the music stops. Everyone will find a lot of vomit and trash to clean up, and it won't feel so fun and you won't feel so good with all that hangover and tab to pay, so make sure you sell your portfolio at the highs and buy your family something nice. The best thing you can do is capitalize on your investment, put your wealth into something classical like gems, silver, gold, and prepare to return to tradition and prepare to cultivate yourselves.
TSX:TOULong
by LordWrymouth
Rogers Communication RCI.B - Weakness AheadI have been following Rogers Communication for a while watching price unfold as the company has been in the news over the last few months. Firstly, Rogers would like to purchase Shaw communications which will constrict wireless competition landscape even further within Canada and secondly, they had a serious country wide outage a few weeks back which affected millions of their consumers as well as businesses such as Interac and emergency services. The outage revealed how vulnerable their infrastructure is to being affected as they appear to have less than reliable redundancy systems in place. Management noted they will be investing heavily into their infrastructure so this downtime issue will not happen again. Millions will be spend on their networks which will likely affect stock price. Looking at the long term monthly timeframe, I see continued weakness in RCI.B after it breached an old Feb-2019 all time high of $73.82 but was strongly rejected with price currently sitting in the middle of the dealing range between $73.82 and $46.81. Under current price, we have a few levels that I believe price will reach for. 1st target = 56.00 2nd target = 54.70 3rd target = 50.70 4th target = 46.80 Ultimate target for the stock in my opinion is $40.0. Feel free to comment on my idea. Feedback is always appreciated.
TSX:RCI.BShort
by DenisRisticFX
PELANGIO EXPLORATION!!!! JR MINER EXPLORER BUY OF THE YEAR!!!!PX is at .03 with a market cap of C$2.6M. Just the Obuasi property alone is worth at least $30M which is 10X the market cap. It is next door to Anglogold Ashanti Obuasi mine and they would snap it up at that price even with no further drilling. Plus they have other assets in Canada and Ghana. Ghana is a very mining friendly country because the government owns a percentage of mines, so they have a vested interest in the mining industry success.
TSXV:PXLong
by allwaysgo
Suncor - Pain to Pleasure and Pleasure to PainThe truth is that the energy sector has been doing really well. WTI Crude appeared to can't stop won't stop, and then Natural Gas appeared to can't stop won't stop. Now, both NG1 and WTI are going to dump as the Federal Reserve points a nuclear bomb at the so-called "inflation," which in reality are high commodities and high stock prices. Shortly it will appear that the Party is over for commodities and stocks, and this will provide a great deal of pain for people who have bought this pullback from $53, not realizing that the knife has yet to cut sufficiently deep. However, natural gas and oil are something that the world cannot do without, for mankind is paralyzed without electricity, and no matter how much of a leftist you want to be and how much of the ESG Kool Aid you've drank, the cold truth is that without coal and natural gas you won't have electricity for your computers, and without oil, you won't have a shipping and transportation network. A fundamental lack of either electricity or transport would threaten the ruling North American Communist Party's stability, and so they will be maintained, but the prices will drive ordinary people out of the market, and you will see social credit and digital identification-based fuel rationing during this time period, if all goes well for the Communist Party. (It won't.) In the process, WTI will set a new high, probably painfully higher than people expect, and in a faster time frame that people expect, but also coming up short of moonboy expectations. I would say that this $350/b as some have predicted is nonsense. I think the number is $180, and then demand destruction will be savagely en route. For Natural Gas, I believe that Henry Hub futures are going to heatseek $18 after a solid clean out, and then the game will quickly wrap itself up. Look on the upside: at least you haven't been paying $40 like Europe and Australia already has for months. All of this means that when everything is scary and prices have been driven deep enough to give you the chance to sell low after buying high, energy stocks will begin a real pump. This pump will serve as a bear trap and will be pretty amusing. Your best bet on Suncor is in the $27 mark with a target above the double top around $62. Frankly, I would say you could see a new all time high over $80, but drawing this on this chart is too hard. Either way with a $27 entry and a $62 target with a stop below $21, you're getting an RR of almost 5. An entry of $34.60 is more "realistic" for many people, so go for that, and just make sure you don't panic sell if terminal velocity continues on. Make sure you sell it _all_ at the peaks and buy your family something nice. Remember: stocks won't buy you rice or gasoline. Cash. Is. King.
TSX:SULong
by LordWrymouth
Independent research report with a 12-month price target of 0.67PlantX Receives Bullish Research Valuation from Capital Y Management VANCOUVER, BC, July 27, 2022 /CNW/ - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company") today announced that Capital Y Management, a New York-based hedge fund, has issued an independent research report on PlantX referring to PlantX as "a market leader with a disruptive business in an emerging industry with long term tailwinds''. Capital Y Management has established a 12-month price target of C$0.67 per common share, which would represent an enterprise value for PlantX of approximately C$68 million. Hedge Fund Places PlantX Target Price at C$0.67 Per Share (CNW Group/PlantX Life Inc.) "The PlantX team is hard at work to make plant-based diets available to everyone, expanding our presence in this rapidly growing market," said PlantX CEO, Lorne Rapkin. "We are encouraged that this independent report has recognized that we are well-positioned. While we are not commenting on the specific projections, we are focused on achieving success similar to Capital Y's outlook."
VLong
by agstockpicks
1